Provided by Tiger Fintech (Singapore) Pte. Ltd.

Global Medical

6.38
+0.15002.41%
Post-market: 6.380.00000.00%19:42 EDT
Volume:668.96K
Turnover:4.27M
Market Cap:426.69M
PE:199.32
High:6.43
Open:6.29
Low:6.28
Close:6.23
Loading ...

Global Medical REIT (GMRE) Receives a Buy from Alliance Global Partners

TIPRANKS
·
29 May

Global Medical price target lowered to $8.50 from $9.50 at Alliance Global

TIPRANKS
·
29 May

Global Medical REIT Reduces Quarterly Dividend to $0.15

TIPRANKS
·
29 May

Global Medical REIT Cuts Quarterly Dividend to $0.15 per Share From $0.21, Payable July 9 to Shareholders of Record June 20

MT Newswires Live
·
29 May

Global Medical REIT Inc - Declares $0.15 per Share Q2 Cash Dividend Payable July 9, 2025

THOMSON REUTERS
·
29 May

Press Release: Global Medical REIT Inc. Board Declares 2025 Second Quarter Common and Preferred Dividends

Dow Jones
·
29 May

Global Medical REIT price target lowered to $7.50 from $9.50 at BMO Capital

TIPRANKS
·
26 May

Global Medical REIT Inc. Concluded Annual Stockholders Meeting

Reuters
·
15 May

Global Medical REIT Reports Steady Q1 2025 Results

TIPRANKS
·
09 May

Global Medical REIT Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

BRIEF-Global Medical REIT Q1 FFO USD 14.779 Million

Reuters
·
08 May

Global Medical REIT Announces First Quarter 2025 Financial Results

THOMSON REUTERS
·
08 May

Global Medical REIT Q1 Ffo USD 14.779 Million

THOMSON REUTERS
·
08 May

Global Medical REIT Inc expected to post earnings of 1 cent a share - Earnings Preview

Reuters
·
06 May

Alexander's (ALX) Q1 FFO Beat Estimates

Zacks
·
05 May

CubeSmart (CUBE) Tops Q1 FFO and Revenue Estimates

Zacks
·
02 May

Global Medical REIT Inc. Announces Dates for 2025 First Quarter Earnings Release and Webcast

Business Wire
·
16 Apr

Global Medical REIT Down Over 8%, On Track for Lowest Close Since April 2018 -- Data Talk

Dow Jones
·
11 Apr

Global Medical REIT (GMRE) Soars 6.4%: Is Further Upside Left in the Stock?

Zacks
·
10 Apr

Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE

Dow Jones
·
03 Apr